Free Trial

Centene (CNC) Stock Price, News & Analysis

Centene logo
$33.28 -0.51 (-1.49%)
Closing price 03:58 PM Eastern
Extended Trading
$33.28 0.00 (0.00%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Centene Stock (NYSE:CNC)

Key Stats

Today's Range
$33.30
$34.84
50-Day Range
$33.80
$62.82
52-Week Range
$33.12
$80.59
Volume
33.74 million shs
Average Volume
5.45 million shs
Market Capitalization
$16.56 billion
P/E Ratio
4.96
Dividend Yield
N/A
Price Target
$68.87
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 100% of companies evaluated by MarketBeat, and ranked 10th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.41, and is based on 7 buy ratings, 10 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Centene has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 7.43% in the coming year, from $6.86 to $7.37 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is 4.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.54.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is 4.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.43.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.68. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    1.89% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 19.05%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.89% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 19.05%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Centene has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 78 news articles for Centene this week, compared to 21 articles on an average week.
  • Search Interest

    57 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 128% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 117% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.36% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

CNC Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Centene's 40% Crash: Generational Buy Or Value Trap?
Centene's 40% Crash: Generational Buy Or Value Trap?
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $60.58 at the beginning of 2025. Since then, CNC shares have decreased by 45.1% and is now trading at $33.2750.

Centene Corporation (NYSE:CNC) posted its quarterly earnings data on Friday, April, 25th. The company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.52 by $0.38. The business's revenue for the quarter was up 15.4% on a year-over-year basis.
Read the conference call transcript
.

Shares of Centene split on the morning of Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were distributed to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more.

Top institutional investors of Centene include Kera Capital Partners Inc. and Harbor Investment Advisory LLC. Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Shannon Bagley, Christopher J Coughlin, Theodore R Samuels II, Richard A Gephardt, Thomas Greco, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/25/2025
Today
7/03/2025
Next Earnings (Estimated)
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
Employees
60,500
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$68.87
High Stock Price Target
$89.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+107.1%
Consensus Rating
Hold
Rating Score (0-4)
2.41
Research Coverage
17 Analysts

Profitability

Trailing P/E Ratio
4.96
Forward P/E Ratio
4.85
P/E Growth
0.68
Net Income
$3.31 billion
Pretax Margin
2.68%

Debt

Sales & Book Value

Annual Sales
$163.07 billion
Cash Flow
$5.81 per share
Price / Cash Flow
5.72
Book Value
$52.49 per share
Price / Book
0.63

Miscellaneous

Free Float
495,812,000
Market Cap
$16.55 billion
Optionable
Optionable
Beta
0.44

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:CNC) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners